Bclx-vMO-mediated splice switch markedly inhibited the proliferation of A172 cells but showed no toxicity in normal astrocyte cells, suggesting that Bcl-xL is essential for GBM cell survival (Fig. 3A). The gene discussed is BCL2L1; the disease is glioblastoma.